Molecule Information
General Information of the Molecule (ID: Mol01288)
| Name |
OIP5 antisense RNA 1 (OIP5-AS1)
,Homo sapiens
|
||||
|---|---|---|---|---|---|
| Synonyms |
OIP5-AS1
Click to Show/Hide
|
||||
| Molecule Type |
LncRNA
|
||||
| Gene Name |
OIP5-AS1
|
||||
| Gene ID | |||||
| Location |
chr15:41283990-41309737[+]
|
||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
2 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Osteosarcoma [ICD-11: 2B51.0] | [1] | |||
| Resistant Disease | Osteosarcoma [ICD-11: 2B51.0] | |||
| Resistant Drug | Cisplatin | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| Cell Pathway Regulation | Cell apoptosis | Inhibition | hsa04210 | |
| Cell proliferation | Activation | hsa05200 | ||
| PI3K/AKT/mTOR signaling pathway | Activation | hsa04151 | ||
| In Vitro Model | MG63 cells | Bone marrow | Homo sapiens (Human) | CVCL_0426 |
| SAOS-2 cells | Bone marrow | Homo sapiens (Human) | CVCL_0548 | |
| In Vivo Model | Nude mouse xenograft model | Mus musculus | ||
| Experiment for Molecule Alteration |
qPCR | |||
| Experiment for Drug Resistance |
CCK8 assay; Flow cytometry assay | |||
| Mechanism Description | OIP5-AS1 regulates cisplatin resistance by activating the PI3k/AkT/mTOR signaling pathway. | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Ovarian cancer [ICD-11: 2C73.0] | [2] | |||
| Resistant Disease | Ovarian cancer [ICD-11: 2C73.0] | |||
| Resistant Drug | Paclitaxel | |||
| Molecule Alteration | Expression | Down-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | A2780 cells | Ovary | Homo sapiens (Human) | CVCL_0134 |
| Experiment for Molecule Alteration |
RT-PCR; LncRNA and mRNA sequencing | |||
| Experiment for Drug Resistance |
CCK8 assay | |||
| Mechanism Description | To further identify the potential mRNA targets of the MDR linked lncRNAs, the 9 potential MDR linked lncRNAs and mRNAs co-expression network was generated. Finally, 1428 mRNAs were considered to be coexpressed with the 9 potential MDR linked lncRNAs (pearson coefficiency >0.90 and q<0.05). In particular, we noticed that lncRNA CTD-2589M5.4 was co-expressed with 806 genes, including the MDR linked genes: ABCB1, ABCB4, ABCC3, and ABCG2 (pearson co-efficiency =0.986, 0.952, 0.961, and 0.999, respectively) and the mesothelin encoded protein MSLN which was considered to be the marker of ovarian cancer, colon cancer and so on. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
